Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined allergen immunotherapy and antibiotics for chronic atopic eczema
2010-021284-33Phase 2Completed
- Sponsor
- John Radcliffe Hospital
- Start
- Oct 2010
- Modality
- Small Molecules, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of Der p Alutard SQ and flucloxacillin in atopic dermatitis (AD), sponsored by John Radcliffe Hospital. Primary endpoint: Clinical severity of eczema (SCORAD). Started Oct 2010; status: completed.
02
Drugs
Der p Alutard SQflucloxacillin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2010-021284-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021284-33.